1. Automated system for diagnosing endometrial cancer by adopting deep-learning technology in hysteroscopy.
- Author
-
Takahashi Y, Sone K, Noda K, Yoshida K, Toyohara Y, Kato K, Inoue F, Kukita A, Taguchi A, Nishida H, Miyamoto Y, Tanikawa M, Tsuruga T, Iriyama T, Nagasaka K, Matsumoto Y, Hirota Y, Hiraike-Wada O, Oda K, Maruyama M, Osuga Y, and Fujii T
- Subjects
- Data Accuracy, Female, Humans, Sensitivity and Specificity, Deep Learning, Early Detection of Cancer methods, Electronic Data Processing methods, Endometrial Hyperplasia diagnosis, Endometrial Neoplasms diagnosis, Hysteroscopy methods, Leiomyoma diagnosis, Polyps diagnosis, Uterine Neoplasms diagnosis
- Abstract
Endometrial cancer is a ubiquitous gynecological disease with increasing global incidence. Therefore, despite the lack of an established screening technique to date, early diagnosis of endometrial cancer assumes critical importance. This paper presents an artificial-intelligence-based system to detect the regions affected by endometrial cancer automatically from hysteroscopic images. In this study, 177 patients (60 with normal endometrium, 21 with uterine myoma, 60 with endometrial polyp, 15 with atypical endometrial hyperplasia, and 21 with endometrial cancer) with a history of hysteroscopy were recruited. Machine-learning techniques based on three popular deep neural network models were employed, and a continuity-analysis method was developed to enhance the accuracy of cancer diagnosis. Finally, we investigated if the accuracy could be improved by combining all the trained models. The results reveal that the diagnosis accuracy was approximately 80% (78.91-80.93%) when using the standard method, and it increased to 89% (83.94-89.13%) and exceeded 90% (i.e., 90.29%) when employing the proposed continuity analysis and combining the three neural networks, respectively. The corresponding sensitivity and specificity equaled 91.66% and 89.36%, respectively. These findings demonstrate the proposed method to be sufficient to facilitate timely diagnosis of endometrial cancer in the near future., Competing Interests: Kenbun Sone has a joint research agreement with Predicthy LLC. Katsuhiko Noda and Kaname Yoshida are members of Predicthy LLC. The other authors have no competing interests to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
- Published
- 2021
- Full Text
- View/download PDF